Amicogen Inc (092040) - Total Liabilities

Latest as of March 2026: ₩80.33 Billion KRW ≈ $54.44 Million USD

Based on the latest financial reports, Amicogen Inc (092040) has total liabilities worth ₩80.33 Billion KRW (≈ $54.44 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 092040 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Amicogen Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Amicogen Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Amicogen Inc (092040) total assets.

Amicogen Inc Competitors by Total Liabilities

The table below lists competitors of Amicogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
S P V I Public Company Limited BK:SPVI	Thailand	฿730.69 Million
Xander International TWO:6118	Taiwan	NT$2.52 Billion
Theragen Etex Co.Ltd KQ:066700	Korea	₩101.29 Billion
Circle8 Group, Inc. NASDAQ:CIRC	USA	$926.31 Million
RFTech Co. Ltd KQ:061040	Korea	₩203.65 Billion
Krynica Vitamin SA WAR:KVT	Poland	zł104.22 Million
Dongyang Expre KO:084670	Korea	₩101.95 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Amicogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Amicogen Inc net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amicogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amicogen Inc (2014–2025)

The table below shows the annual total liabilities of Amicogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩136.00 Billion ≈ $92.17 Million	-20.80%
2024-12-31	₩171.73 Billion ≈ $116.38 Million	-30.79%
2023-12-31	₩248.12 Billion ≈ $168.15 Million	-16.70%
2022-12-31	₩297.86 Billion ≈ $201.85 Million	+32.34%
2021-12-31	₩225.06 Billion ≈ $152.52 Million	+72.56%
2020-12-31	₩130.43 Billion ≈ $88.39 Million	+9.28%
2019-12-31	₩119.35 Billion ≈ $80.88 Million	+14.84%
2018-12-31	₩103.93 Billion ≈ $70.43 Million	+39.83%
2017-12-31	₩74.32 Billion ≈ $50.37 Million	+14.71%
2016-12-31	₩64.79 Billion ≈ $43.91 Million	-16.65%
2015-12-31	₩77.74 Billion ≈ $52.68 Million	+1688.10%
2014-12-31	₩4.35 Billion ≈ $2.95 Million	--

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.35 Million

₩63.97 Billion KRW

Market Cap Rank

#22510 Global

#1445 in Korea

Share Price

₩908.00

Change (1 day)

+2.71%

52-Week Range

₩822.00 - ₩4030.00

All Time High

₩22094.22